OneMedNet Corp
corporate_fare Company Profile
OneMedNet Corp (NASDAQ:ONMD) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 38 items for ONMD at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-03, rated 7/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 11 rated 8 or above. Recent SEC coverage for ONMD spans 4, 8-K, 424B3, DEF 14A.
Recent high-impact activity:
- OneMedNet Lands High Six-Figure Add-On Order, Lifting Data Volume 150%
- Director Kosasa Thomas Adds $750K OneMedNet Stake at $5.78
- CMO Yu Jeffrey Invests $250K in OneMedNet at $5.54 Per Share
- OneMedNet Inks Seven-Figure Multiyear Data Deal With Sublicensing Upside
- OneMedNet Locks In 1-for-10 Reverse Split to Regain Nasdaq Compliance
Financial Snapshot
Short Interest & Short Volume
3.48 days to coverFINRA reported short interest of 151,048 shares in ONMD as of the October 15, 2026 settlement, a 33.0% increase from the prior period — about 3.5 days to cover at its recent average daily volume. On November 3, 2026, 73.7% of ONMD volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.
Dilution Risk
High riskFiling-implied dilution signals for ONMD, detected from its recent SEC filings · based on capital-structure filings through 2026-07-01.
Going Concern Warning Issued · Nasdaq Delisting Threat
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →